Related Experiment Video
Updated: Jun 27, 2025

04:38
A Murine Tail Lymphedema Model
Published on: February 10, 2021
5.7K
Quantification of Lymphangiogenesis in the Murine Lymphedema Tail Model Using Intravital Microscopy
Ganesh Mohan1, Imran Khan1, Stephanie M Diaz1
1Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Lymphatic Research and Biology
|May 3, 2024
Summary
This study shows intravital microscopy (IVM) can visualize lymphatic growth in live mice with lymphedema. Gene therapy using tissue nanotransfection (TNT) with Prox1 enhanced lymphatic function and reduced swelling.
Area of Science:
- Biomedical Engineering
- Vascular Biology
- Regenerative Medicine
Background:
- Lymphedema, a chronic swelling from lymphatic dysfunction, affects millions with no cure.
- Assessing lymphatic growth is crucial for developing new lymphedema therapeutics.
- Intravital microscopy (IVM) offers powerful in vivo imaging for biological processes.
Purpose of the Study:
- To evaluate the applicability of IVM for visualizing and quantifying lymphatic vessels.
- To assess lymphangiogenesis in a live murine tail lymphedema model using IVM.
- To investigate the efficacy of gene-based therapy delivered via tissue nanotransfection (TNT).
Main Methods:
- A murine tail lymphedema model was established.
- Tissue nanotransfection (TNT) delivered genetic cargo (pCMV6-Prox1 or pCMV6 control) to the surgical site.
- Confocal/multiphoton microscopy analyzed FITC-dextran stained lymphatic vessels and branch points.
Main Results:
- The TNT-Prox1 group showed reduced lymphedema and increased lymphatic distribution compared to controls.
- Over threefold more lymphatic branching points were observed in the TNT-Prox1 group.
- IVM successfully visualized and quantified lymphatic changes in vivo.
Conclusions:
- IVM is a novel and effective tool for studying lymphatic vessels in live lymphedema models.
- IVM enables functional assessment and visualization of lymphangiogenesis after gene therapy.
- This approach aids in evaluating novel therapeutics for lymphedema.

